10.3978/j.issn.1000-9604.2014.12.19
Efficacy of third-line pemetrexed monotherapy versus pemetrexed combination with bevacizumab in patients with advanced EGFR mutation-positive lung adenocarcinoma
26
This study was funded by National Key Scientific & Technology Support Program:Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer 2013BAI09B09
2015-01-23(万方平台首次上网日期,不代表论文的发表时间)
共6页
705-710